I

INmune Bio
D

INMB

6.43000
USD
0.23
(3.71%)
Market Closed
Volume
15,569
EPS
0
Div Yield
0
P/E
-3
Market Cap
127,514,558
OverviewSignalsIdeasNews
Related Instruments
    A
    ADUS
    0.470
    (0.39%)
    121.850 USD
    A
    APLS
    -3.615
    (-9.12%)
    36.005 USD
    A
    ARWR
    -1.160
    (-4.06%)
    27.410 USD
    A
    ASND
    2.930
    (2.20%)
    136.370 USD
    A
    ATAI
    -0.14000
    (-8.97%)
    1.42000 USD
    A
    ATUS
    -0.23000
    (-10.95%)
    1.87000 USD
    A
    AXLA
    -1.05000
    (-18.82%)
    4.53000 USD
    B
    BLUE
    -0.06000
    (-5.26%)
    1.08000 USD
    B
    BMRN
    0.270
    (0.32%)
    84.620 USD
    C
    CENT
    -0.470
    (-1.18%)
    39.520 USD
    C
    CRVS
    0.36000
    (13.85%)
    2.96000 USD
    CRWD
    -7.780
    (-3.35%)
    224.170 USD
    D
    DCPH
    0
    (0%)
    0.000000 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    F
    FATE
    -0.46000
    (-8.61%)
    4.88000 USD
    F
    FIXX
    0
    (0%)
    0.000000 USD
    F
    FREQ
    0
    (0%)
    0.000000 USD
    G
    GH
    -1.770
    (-5.04%)
    33.380 USD
    G
    GNFT
    0.10000
    (2.41%)
    4.25000 USD
    G
    GTHX
    -0.11000
    (-2.56%)
    4.19000 USD
    I
    IONS
    1.830
    (3.70%)
    51.330 USD
    K
    KRYS
    -10.290
    (-4.93%)
    198.500 USD
    K
    KURA
    -0.630
    (-3.03%)
    20.190 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    M
    MYOV
    0
    (0%)
    0.000000 USD
    N
    NKTR
    -0.10000
    (-7.38%)
    1.25500 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    O
    ONCT
    -0.15000
    (-2.28%)
    6.43000 USD
    P
    PEN
    3.960
    (2.37%)
    171.260 USD
    P
    PLX
    -0.02000
    (-1.85%)
    1.06000 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    S
    SNDX
    -0.750
    (-3.30%)
    21.990 USD
    T
    TDOC
    -0.85000
    (-9.00%)
    8.59000 USD
    V
    VIR
    -0.43000
    (-4.22%)
    9.75000 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
News

Title: INmune Bio

Sector: Healthcare
Industry: Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.